In the segment, while products like Nucala and Dovato are key top-line drivers, new long-acting HIV medicines, Cabenuva and ...

When the Centers for Disease Control and Prevention (CDC) released its 2022 STI surveillance report, it was far from a clean ...

A promising new antibiotic, gepotidacin, emerged as a potential weapon against drug-resistant gonorrhea, according to a recent study published in The Lancet. The clinical trial, involving 628 ...

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved since the 1990s.

MONDAY, April 21, 2025 (HealthDay News) -- For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone plus azithromycin, according ...

A new antibiotic, gepotidacin, shows promise in treating gonorrhea and UTIs in women, with potential as a convenient alternative to current treatments.

A newly approved antibiotic to treat urinary tract infections, gepotidacin, also may help fight drug-resistant gonorrhea, a new study shows.

The company first announced gepotidacin’s efficacy against gonorrhea at the same microbiology conference last year, but The Lancet paper is the first to publish specific details and results from ...

Scientists have found a new antibiotic that could treat gonorrhoea, the first breakthrough in treating the sexually transmitted infection in more than 30 years. Experts believe gepotidacin, an ...

Study suggests that gepotidacin – which is taken as a pill – may help treat cases and could potentially help to alleviate the threat of treatment-resistant gonorrhoea infections Experts ...